Page last updated: 2024-12-08
diplacin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diplacin: RN given refers to dichloride; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 159876 |
MeSH ID | M0045258 |
Synonyms (16)
Synonym |
---|
diplatsin |
1h-pyrrolizinium, 4,4'-(m-phenylenebis(oxyethylene))bis(hexahydro-1-hydroxy-7-(hydroxymethyl)-, dichloride |
diplacine |
diplacin |
19918-85-5 |
AKOS005267162 |
FT-0682995 |
4-[2-[3-[2-[1-hydroxy-7-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1h-pyrrolizin-4-ium-4-yl]ethoxy]phenoxy]ethyl]-7-(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1h-pyrrolizin-4-ium-1-ol;dichloride |
4,4'-[1,3-phenylenebis(oxyethane-2,1-diyl)]bis[1-hydroxy-7-(hydroxymethyl)hexahydro-1h-pyrrolizinium] dichloride |
diplacine dichloride |
Q4162034 |
4,4'-(2,2'-(1,3-phenylenebis(oxy))bis(ethane-2,1-diyl))bis-(1-hydroxy-7-(hydroxymethyl)octahydropyrrolizinium) chloride |
DTXSID90941832 |
4,4'-[1,3-phenylenebis(oxyethane-2,1-diyl)]bis[1-hydroxy-7-(hydroxymethyl)hexahydro-1h-pyrrolizin-4-ium] dichloride |
SB67371 |
4,4'-[1,3-phenylenebis(oxy-2,1-ethanediyl)]bis[1-h ydroxy-7-(hydroxymethyl)hexahydro-1h-pyrrolizinium |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.45
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.45) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 19 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |